Drug development
Pre-launch
Launch
Post-launch
Maturity
Patient insights
Assess disease burden and unmet needs to guide drug discovery
Disease insights
Guide brand positioning, patient messaging, and communications
Competitive intelligence
Analogue benchmarking, digital strategies, and online sentiment analysis
KOLs and patient influencers
Engage influencers to drive education, adoption, and brand credibility
Conference insights
Track HCP opinions and optimize conference participation
Online stakeholder opinion
Monitor real-time feedback from HCPs, patients, and other online users
Signal detection
Monitor crises and protect
brand reputation
Continuous monitoring
Track launch awareness, sentiment, virality, and stakeholder reactions to evaluate launch impact
Campaign insights
Monitor shifts in therapy area awareness, baseline, and online activity
Clinical trial insights
Support recruitment, trial design, and protocol development
Brand sentiment and perception
Track patient voice, drug adoption, and barriers to
assess brand sentiment
and support post-marketing surveillance
Brand sentiment
and perception
Track patient voice, drug adoption, and barriers to assess brand sentiment and support post-marketing surveillance
Treatment journey insights
Optimize patient engagement, adherence strategies, and
brand positioning
Competitive intelligence
Monitor threats, adapt to market shifts, and assess market sentiment around loss of exclusivity (LOE)
Pre-
launch
Drug
development
Launch
Post-
launch
Maturity
Digital landscape
Track trends, innovations, digital activity, and competitors
This slide demonstrates the nature of insights that social listening can provide at various stages of the drug lifecycle. This is only suggestive and non-exhaustive
Digital landscape
Track trends, innovations, digital activity, and competitors
Brand insights
Sustain engagement, refine positioning, and support drug lifecycle strategies
Treatment journey insights
Optimize patient engagement, adherence strategies, and
brand positioning
Integrating social insights into drug development and strategy
Social listening across the drug lifecycle